Acadia Pharmaceuticals Stock
Acadia Pharmaceuticals Stock
We can see a decrease in the price for Acadia Pharmaceuticals. Compared to yesterday it has lost -€0.360 (-1.870%).
With 35 Buy predictions and 1 Sell predictions Acadia Pharmaceuticals is one of the favorites of our community.
As a result the target price of 27 € shows a positive potential of 40.3% compared to the current price of 19.25 € for Acadia Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Acadia Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Acadia Pharmaceuticals in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Acadia Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals | -1.870% | 1.077% | -1.358% | 25.293% | -17.155% | 10.961% | -11.436% |
| United Therapeutics | -1.950% | 4.439% | 11.379% | 69.931% | 14.533% | 143.725% | 198.415% |
| Ionis Pharmaceuticals Inc. | 0.830% | 0.621% | -7.530% | 144.957% | -4.591% | 96.634% | 69.428% |
| Novocure Ltd | -2.330% | -10.373% | -20.883% | -44.694% | -19.347% | -83.519% | -91.924% |
Comments
ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals (ACAD) had its price target raised by JPMorgan Chase & Co. from $31.00 to $34.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals (ACAD) had its price target raised by TD Cowen from $35.00 to $37.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat